Cholesterol disorders affect millions of people globally and are among the leading risk factors for cardiovascular diseases, including heart attack and stroke. Statins are the first-line therapy for ...

Anthracyclines are widely used to treat hematological and solid-tumor cancers, but past research suggests their use may be associated with late cardiac effects, including heart failure, among patients ...

Recent research suggests that the majority of side effects commonly linked to statins are not, in fact, caused by the medication itself. A comprehensive study, published in The Lancet, examined data ...

Statins reduce the incidence of cardiovascular events in persons with type 2 diabetes mellitus. However, the benefit of statins in such patients receiving hemodialysis, who are at high risk for ...

NEW ORLEANS -- Patients with lymphoma on anthracycline-based chemotherapy who took atorvastatin (Lipitor) for a year were less likely to experience cardiac dysfunction, according to the STOP-CA trial.

More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October about an extensive recall of thousands of bottles of atorvastatin, the generic ...

Among those with CAD, both rosuvastatin and atorvastatin are similarly effective regarding the combination of all-cause death, MI, stroke, or any coronary revascularization over 3 years, according to ...

Please provide your email address to receive an email when new articles are posted on . Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For patients with COVID-19 admitted to intensive care, giving atorvastatin 20 mg/d did not result ...

Please provide your email address to receive an email when new articles are posted on . Assigning pitavastatin or atorvastatin to patients with acute coronary syndromes was associated with a reduction ...

Newark, New Castle, USA, June 19, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Growth Plus Reports, the global atorvastatin drug market was valued at US$ 4.55 billion in 2022 and is ...